TLRS mediates the role and mechanism of M.Furfur In promoting psoriasis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000032637

Enrollment

Unknown

Registered

2020-05-04

Start date

2020-05-05

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

M.Furfur positive vs. negative psoriasis patients:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients of 18-75 years old with psoriasis, male or female.

Exclusion criteria

Exclusion criteria: 1. Thore with other systemic systemic diseases and/or abnormal mental disorders. 2. Those who took or applied anti-psoriasis drugs within 2 weeks before the treatment period. 3. Those with severe diabetes or heart, liver and kidney damage. 4. Those who are known to have severe immune dysfunction or need to take glucocorticoids and immunosuppressants for a long time.

Design outcomes

Primary

Measure	Time frame
the results of M.Furfur culture;the expression of TLRs signaling pathway in the skin lesion;	—

Countries

China

Contacts

Public ContactFu Hongyang

The First Affiliated Hospital of Zhejiang University of traditional Chinese Medicine

1103420602@qq.com+86 18758202314

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026